AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Bovine collagen peptide vaccine modulates severity of arthritis.

Vaccine Weekly

| August 04, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 AUG 4 - (NewsRx.com & NewsRx.net) -- Vaccination with an immunodominant peptide of bovine type II collagen induces an anti-TCR response, and modulates the onset and severity of collagen-induced arthritis.

According to a study from Japan, "T cell responses directed toward TCR-derived peptides have been shown to be an important regulatory mechanism of protection against autoimmunity. Here, we show that a naturally induced TCR-directed immune response can delay the onset of collagen-induced arthritis (CIA), an animal model of autoimmune rheumatoid arthritis in humans. DBA/1 mice were pretreated with an immunodominant peptide, p245-270, from bovine type II collagen (bCII) and were subsequently immunized with whole bCII for the induction of arthritis."

"The results showed that preactivation of p245-270-reactive cells delayed the onset and reduced the severity of CIA, compared with animals in the control group," reported Aki Honda and colleagues at the University of Tokyo. "Interestingly, the serum antibody response to bCII and the bCII-specific cytokine were not affected under these conditions. This result indicates that the observed protection was neither directly due to a lower antibody response nor due to the immune deviation of the anti-bCII T cell response. Furthermore, immunization with p245-270, but not bCII, induced a ...

Related articles from newspapers, magazines, journals, and more
Poxvirus used for delivery of stimulatory molecules to melanoma tumors.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Delivery, Skin Cancer, Dermatology, Immunotherapy, Vaccine Development, and Oncology. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Broadly cross-reactive HIV-neutralizing antibody Fab identified.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Therapy, Vaccine Development, Monoclonal Antibodies, Diagnostics, and Immunotherapy. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Arginine-glysine-aspartate motif enhances immunogenicity of antigens.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Delivery, Vaccine Development, Vaccine Efficacy, Immunology, and Immunotherapy. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Cancer vaccine using low affinity epitopes proves successful in mice.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...This article may be viewed at https://www.the-jci.org/press/19418.pdf. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
DNA induces T helper type 1-mediated responses in antigen-primed mice.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Bacteriology, Biological Therapy, Immunology, Immunotherapy, Oncology, and Proteomics. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Researcher reviews novel cancer vaccines.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Vaccine Development, Vaccine Efficacy, Immunotherapy, Proteomics, and Oncology. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Call for increase in flu vaccination among young children.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...administration should make it possible to increase the use of influenza vaccination." This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Positive results of cholera vaccine trial in Bangladesh reported.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...vaccines against anthrax or other organisms that might be used as biowarfare agents. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Typhoid/hepatitis A vaccine effective as booster dose in primed adults.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Vaccine Efficacy, Vaccine Development, Hepatitis A Virus, Virology, and Hepatology. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
Lock to food-borne pathogen pathway may be key to vaccine.
Newspaper article from: Vaccine Weekly February 18, 2004 700+ words
...Medicine and the U.S. Department of Agriculture-Agricultural Research Service. This article was prepared by Vaccine Weekly editors from staff and other reports. Copyright 2004, Vaccine Weekly via NewsRx.com & NewsRx.net.
For more facts and information, see all results

Source: HighBeam Research, Bovine collagen peptide vaccine modulates severity of arthritis.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA